PRSS50 and gastric cancer: We found that in gastric cancer tissues which showed low expression of TSP50, 60.1% cases maintained high expression of E-Cadherin whereas in those which showed high expression of TSP50, only 37.2% cases remained to be high expression for E-Cadherin.